JP2015512936A5 - - Google Patents

Download PDF

Info

Publication number
JP2015512936A5
JP2015512936A5 JP2015505730A JP2015505730A JP2015512936A5 JP 2015512936 A5 JP2015512936 A5 JP 2015512936A5 JP 2015505730 A JP2015505730 A JP 2015505730A JP 2015505730 A JP2015505730 A JP 2015505730A JP 2015512936 A5 JP2015512936 A5 JP 2015512936A5
Authority
JP
Japan
Prior art keywords
fucosyl
sialyl lactose
prebiotic composition
oligosaccharide
sialyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015505730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015512936A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/030764 external-priority patent/WO2013154725A1/en
Publication of JP2015512936A publication Critical patent/JP2015512936A/ja
Publication of JP2015512936A5 publication Critical patent/JP2015512936A5/ja
Pending legal-status Critical Current

Links

JP2015505730A 2012-04-13 2013-03-13 プレバイオティクス組成物およびその使用方法 Pending JP2015512936A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261623868P 2012-04-13 2012-04-13
US61/623,868 2012-04-13
PCT/US2013/030764 WO2013154725A1 (en) 2012-04-13 2013-03-13 Prebiotic compositions and methods of use

Publications (2)

Publication Number Publication Date
JP2015512936A JP2015512936A (ja) 2015-04-30
JP2015512936A5 true JP2015512936A5 (https=) 2016-05-12

Family

ID=49328018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015505730A Pending JP2015512936A (ja) 2012-04-13 2013-03-13 プレバイオティクス組成物およびその使用方法

Country Status (6)

Country Link
US (1) US20150265661A1 (https=)
EP (1) EP2836218A4 (https=)
JP (1) JP2015512936A (https=)
CN (1) CN104507483A (https=)
MX (1) MX2014012362A (https=)
WO (1) WO2013154725A1 (https=)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2651067T3 (es) 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2014036182A2 (en) 2012-08-29 2014-03-06 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP2885977A1 (en) * 2013-12-19 2015-06-24 Agriculture and Food Development Authority (TEAGASC) An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
PL3209673T5 (pl) 2014-10-24 2023-10-23 Glycom A/S Mieszaniny hmo
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
EP3212197A4 (en) 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
EP3212198B1 (en) * 2014-10-29 2020-12-23 Glycom A/S Synthetic composition and method for promoting mucosal healing
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
CA2966360C (en) 2014-10-30 2023-09-05 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
WO2016069801A1 (en) 2014-10-30 2016-05-06 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodecelopmental disorders
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
EP3229812A4 (en) 2014-12-08 2018-10-03 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
AR103260A1 (es) * 2014-12-23 2017-04-26 4D Pharma Res Ltd Modulación inmunitaria
EP3400953A1 (en) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirin polypeptide and immune modulation
AU2018205072B2 (en) * 2014-12-23 2020-05-21 Cj Bioscience, Inc. Immune modulation
EP3288389A4 (en) 2015-04-28 2018-10-10 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SMT201900588T1 (it) 2015-06-15 2019-11-13 4D Pharma Res Limited Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
US10780103B2 (en) 2015-10-28 2020-09-22 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
PL3368046T3 (pl) * 2015-10-28 2022-11-28 Glycom A/S Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania
EP3377071B1 (en) * 2015-11-17 2024-01-10 Glycom A/S Human milk oligosaccharides for treating antibiotic associated complications
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3389668A4 (en) 2015-12-15 2019-08-21 Glycom A/S MIXTURE OF HMOS
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
ME03487B (me) 2016-03-04 2020-01-20 4D Pharma Plc Kompozicije koje sadrže blautia bakterijske sojeve za liječenje visceralne hipersenzitivnosti
EP3429604A1 (en) 2016-03-14 2019-01-23 Holobiome, Inc. Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
DK3452050T3 (da) * 2016-05-05 2023-02-20 Glycom As Composition comprising hmos for the treatment of noninfectious diarrhoea
US11224605B2 (en) 2016-05-19 2022-01-18 Glycom A/S Synthetic composition
EP4548925A3 (en) 2016-07-01 2025-07-09 Infinant Health, Inc Method for facilitating maturation of the mammalian immune system
TWI802545B (zh) 2016-07-13 2023-05-21 英商4D製藥有限公司 包含細菌菌株之組合物
SG10202100843TA (en) 2016-07-28 2021-03-30 Fonterra Cooperative Group Ltd Dairy product and process
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US11566238B2 (en) 2016-12-15 2023-01-31 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
WO2018155995A1 (ko) * 2017-02-27 2018-08-30 한국생명공학연구원 시아릴락토오스를 유효성분으로 포함하는 항균용 조성물
JP2020513014A (ja) * 2017-04-07 2020-04-30 チルドレンズ ホスピタル メディカル センター 2’−フコシルラクトース化合物による炎症性腸疾患の治療
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
SMT202000555T1 (it) 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
CA3066189A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
CN111356461A (zh) * 2017-10-04 2020-06-30 加利福尼亚大学董事会 免疫调节性低聚糖
KR102741265B1 (ko) * 2017-11-30 2024-12-11 글리콤 에이/에스 미생물총 조절을 위한 인간 밀크 올리고당 및 그의 합성 조성물
WO2019123316A1 (en) * 2017-12-22 2019-06-27 Glycom A/S Composition comprising hmos for preventing or reducing nociception
AU2019232004A1 (en) * 2018-03-08 2020-10-01 Plexus Worldwide Llc Compositions and methods for skin renewal
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
WO2020174386A1 (en) 2019-02-25 2020-09-03 Nutribam Bvba Composition, food supplement and method for supporting and/or improving intestinal health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
CN110257299B (zh) * 2019-07-11 2022-06-10 锦州医科大学 一种阴沟肠杆菌在促进反刍动物生长的应用
CN112869168B (zh) * 2019-11-29 2023-06-06 内蒙古伊利实业集团股份有限公司 可提高胃肠道免疫能力的益生菌益生元组合物及其应用
JP7474596B2 (ja) * 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
CN111363671B (zh) * 2020-02-26 2023-07-21 天津医科大学 一种肠道厌氧微生物培养瓶及其制备方法
WO2021197492A1 (zh) * 2020-04-03 2021-10-07 内蒙古伊利实业集团股份有限公司 可提升生物体对金黄色葡萄球菌感染的抵御能力的母乳低聚糖
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元(广州)健康产品有限公司 一种减少肠道气体产生的组合物
CN112841543A (zh) * 2021-01-28 2021-05-28 重庆周师兄餐饮文化有限公司 一种麻辣脆的加工方法
MX2023008202A (es) 2021-01-29 2023-07-18 Nestle Sa Mezcla de hmo y bifidobacteria.
CN112890200B (zh) * 2021-03-08 2021-11-12 合生元(广州)健康产品有限公司 用于促进低体重婴幼儿生长追赶的一种营养组合物
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
AU2022307441A1 (en) * 2021-07-09 2024-01-25 Société des Produits Nestlé S.A. Uses of bifidobacterium longum transitional microorganism
CN113796545B (zh) * 2021-09-13 2022-09-13 合生元(广州)健康产品有限公司 调节肠道免疫功能的母乳低聚糖组合物及其应用
KR102411242B1 (ko) * 2021-10-18 2022-06-22 큐티스바이오 주식회사 클렙시엘라 아에로제네스의 피부 상태 개선 용도
DK202200588A1 (en) 2022-06-20 2024-02-23 Dsm Ip Assets Bv Mixture of fucosylated HMOs
CN115920013A (zh) * 2022-11-15 2023-04-07 合生元(广州)健康产品有限公司 乳源成分在降低单增李斯特菌引起的感染风险中的应用
CN116042486B (zh) * 2023-02-22 2024-11-08 高邮市人民医院 一种用于治疗动脉粥样硬化的复合菌制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US20060127546A1 (en) * 2004-08-27 2006-06-15 Purac Biochem B.V. Use of glycine and/or glycine derivatives as antibacterial agent against gram negative bacterial pathogens in foods and/or drinks
ES2651067T3 (es) * 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
CN102858191A (zh) * 2010-04-27 2013-01-02 N.V.努特里奇亚 6’-唾液酸化乳糖在婴儿和幼儿营养物中的用途
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
CA2822219C (en) * 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
PT2672844E (pt) * 2011-02-10 2015-02-04 Nestec Sa Modulação do crescimento de bifidobactérias utilizando uma combinação de oligossacáridos identificados no leite humano

Similar Documents

Publication Publication Date Title
JP2015512936A5 (https=)
CN302072736S (zh) 水龙头(hda1715l)
CN302064961S (zh) 水龙头(hda1815l)
CN302082441S (zh) 水龙头(hda1818xh)
CN302061246S (zh) 门夹(2745)
CN302533123S (zh) 全封闭冰箱门锁(二)
CN302155520S (zh) 水龙头(面盆-0008)
CN302357289S (zh) 炕几(816095)
CN302570606S (zh) 洋间扇(s35115r、s35116rt)
CN302487805S (zh) 拉手(5)
CN302134782S (zh) 水龙头(面盆-0007)
CN302155521S (zh) 水龙头(面盆-0006)
CN302533098S (zh) 拉手(1)
CN302533124S (zh) 全封闭冰箱门锁(一)
CN302527073S (zh) 冰箱(123)
CN302527076S (zh) 冰箱(114)
CN302221899S (zh) 盥洗台(y-02)
CN302043104S (zh) 墙壁插座(欧基tl2322)
CN302520114S (zh) Pvc消音地板(02)
CN302250786S (zh) 三门酒柜(88870)
CN302552769S (zh) 花洒(th3190)
CN302439651S (zh) 锁内面板(04款)
CN302494849S (zh) 门锁前锁体(圆形/椭圆形)
CN302103675S (zh) 柜子(y-06)
CN302176827S (zh) 淋浴龙头(0025)